Clinical significance of heparanase activity in primary resected non-small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Lung Cancer

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.LUNGCAN.2004.02.007PMID 15246192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heparanase mediates cell adhesion independent of its enzymatic activity

  2003cited by this paper
• Heparanase Expression Correlates with Invasion and Poor Prognosis in Gastric Cancers

  2003cited by this paper
• Heparanase affects adhesive and tumorigenic potential of human glioma cells.

  2003cited by this paper
• Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.

  2003cited by this paper
• Quantitative Analysis of Heparanase Gene Expression in Esophageal Squamous Cell Carcinoma

  2003cited by this paper
• Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma.

  2003cited by this paper
• Detection of Micrometastatic Tumor Cells in pN0 Lymph Nodes of Patients With Completely Resected Nonsmall Cell Lung Cancer: Impact on Recurrence and Survival

  2002cited by this paper
• Heparanase: A Key Enzyme in Invasion and Metastasis of Gastric Carcinoma

  2002cited by this paper
• Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

  2002cited by this paper
• Heparanase-1 expression is associated with the metastatic potential of breast cancer.

  2002cited by this paper
• Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis

  2002cited by this paper
• Prognostic factors in non-small cell lung cancer: a decade of progress.

  2002cited by this paper
• Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma

  2002cited by this paper
• Human heparanase-1 gene expression in pancreatic adenocarcinoma

  2002cited by this paper
• Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

  2001cited by this paper
• Expression of three extracellular matrix degradative enzymes in bladder cancer

  2001cited by this paper
• Heparanase expression in primary and metastatic pancreatic cancer.

  2001cited by this paper
• Prognostic molecular markers in non-small cell lung cancer.

  2001cited by this paper
• Expression of heparanase in oral cancer cell lines and oral cancer tissues.

  2001cited by this paper
• Heparanase gene expression and metastatic potential in human gastric cancer.

  2001cited by this paper
• Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans.

  2001cited by this paper
• Heparanase expression in clinical digestive malignancies.

  2001cited by this paper
• Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.

  2001cited by this paper
• Loss of Syndecan‐1 and Increased Expression of Heparanase in Invasive Esophageal Carcinomas

  2001cited by this paper
• The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

  2001cited by this paper
• A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.

  2000cited by this paper
• Heparanase: Breaking down barriers in tumors

  1999cited by this paper
• Processing of the Human Heparanase Precursor and Evidence That the Active Enzyme Is a Heterodimer*

  1999cited by this paper
• Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

  1999cited by this paper
• Cloning and functional expression of a human heparanase gene.

  1999cited by this paper
• Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

  1999cited by this paper
• Human Heparanase

  1999cited by this paper
• Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.

  1997cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH

  1995cited by this paper
• Heparanases and tumor metastasis

  1988cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Oncologic Outcomes of Surgery Versus SBRT for Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis.

  2020cites this paper
• Beyond anticoagulant: Heparin as a potential anti-cancer agent

  2014cites this paper
• Significance of Heparanase in Cancer and Inflammation

  2012cites this paper
• A small oxazine compound as an anti-tumor agent: a novel pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-α.

  2010cites this paper
• Heparin and survival in cancer patients.

  2010cites this paper
• Genomics of lung cancer may change diagnosis, prognosis and therapy

  2009cites this paper
• Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.

  2009cites this paper
• UvA-DARE ( Digital Academic Repository ) Coagulation , angiogenesis and cancer

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) Coagulation , angiogenesis and cancer

  2008cites this paper
• Development in anticoagulant therapy.

  2008cites this paper
• Cancer and thrombosis: from molecular mechanisms to clinical presentations

  2007cites this paper
• The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.

  2007cites this paper
• Mechanisms of heparin induced anti-cancer activity in experimental cancer models.

  2007cites this paper
• Heparanase expression: a potential ancillary diagnostic tool for distinguishing between malignant cells and reactive mesothelium in body cavity effusions

  2007cites this paper
• Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.

  2007cites this paper
• Development of heparanase inhibitors for anti-cancer therapy.

  2006cites this paper
• A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor‐induced tumour angiogenesis and heparanase activity

  2005cites this paper
• Heparanase expression in both normal endometrium and endometrial cancer

  2005cites this paper